ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic Proteins and Oral Vaccines Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-32G13973
Home | Market Reports | Health| Pharmacy
Global Therapeutic Proteins and Oral Vaccines Market Research Report 2023
BUY CHAPTERS

Global Therapeutic Proteins and Oral Vaccines Market Research Report 2025

Code: QYRE-Auto-32G13973
Report
July 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Amgen Inc
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer Inc
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience

Therapeutic Proteins and Oral Vaccines Market Size

The global market for Therapeutic Proteins and Oral Vaccines was valued at US$ 474 million in the year 2024 and is projected to reach a revised size of US$ 704 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Therapeutic Proteins and Oral Vaccines Market

Therapeutic Proteins and Oral Vaccines Market

Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Proteins and Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Proteins and Oral Vaccines.
The Therapeutic Proteins and Oral Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Proteins and Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Proteins and Oral Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Therapeutic Proteins and Oral Vaccines Market Report

Report Metric Details
Report Name Therapeutic Proteins and Oral Vaccines Market
Accounted market size in year US$ 474 million
Forecasted market size in 2031 US$ 704 million
CAGR 5.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Therapeutic Proteins
  • Oral Vaccines
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Amgen, Biogen, Eli Lilly and Company, Roche, Johnson and Johnson, Merck, Novo Nordisk, Pfizer, Sanofi, Serum Institute of India, Emergent Biosolutions, TransAlgae, MigVax, Lumen Bioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Therapeutic Proteins and Oral Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Therapeutic Proteins and Oral Vaccines Market growing?

Ans: The Therapeutic Proteins and Oral Vaccines Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Therapeutic Proteins and Oral Vaccines Market size in 2031?

Ans: The Therapeutic Proteins and Oral Vaccines Market size in 2031 will be US$ 704 million.

Who are the main players in the Therapeutic Proteins and Oral Vaccines Market report?

Ans: The main players in the Therapeutic Proteins and Oral Vaccines Market are Abbott, Amgen, Biogen, Eli Lilly and Company, Roche, Johnson and Johnson, Merck, Novo Nordisk, Pfizer, Sanofi, Serum Institute of India, Emergent Biosolutions, TransAlgae, MigVax, Lumen Bioscience

What are the Application segmentation covered in the Therapeutic Proteins and Oral Vaccines Market report?

Ans: The Applications covered in the Therapeutic Proteins and Oral Vaccines Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Therapeutic Proteins and Oral Vaccines Market report?

Ans: The Types covered in the Therapeutic Proteins and Oral Vaccines Market report are Therapeutic Proteins, Oral Vaccines

Recommended Reports

Vaccine Markets

Vaccine Technology & Delivery

Therapeutic & Oral Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Therapeutic Proteins
1.2.3 Oral Vaccines
1.3 Market by Application
1.3.1 Global Therapeutic Proteins and Oral Vaccines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Proteins and Oral Vaccines Market Perspective (2020-2031)
2.2 Global Therapeutic Proteins and Oral Vaccines Growth Trends by Region
2.2.1 Global Therapeutic Proteins and Oral Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Therapeutic Proteins and Oral Vaccines Historic Market Size by Region (2020-2025)
2.2.3 Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Region (2026-2031)
2.3 Therapeutic Proteins and Oral Vaccines Market Dynamics
2.3.1 Therapeutic Proteins and Oral Vaccines Industry Trends
2.3.2 Therapeutic Proteins and Oral Vaccines Market Drivers
2.3.3 Therapeutic Proteins and Oral Vaccines Market Challenges
2.3.4 Therapeutic Proteins and Oral Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Proteins and Oral Vaccines Players by Revenue
3.1.1 Global Top Therapeutic Proteins and Oral Vaccines Players by Revenue (2020-2025)
3.1.2 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Players (2020-2025)
3.2 Global Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Therapeutic Proteins and Oral Vaccines Revenue
3.4 Global Therapeutic Proteins and Oral Vaccines Market Concentration Ratio
3.4.1 Global Therapeutic Proteins and Oral Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Proteins and Oral Vaccines Revenue in 2024
3.5 Global Key Players of Therapeutic Proteins and Oral Vaccines Head office and Area Served
3.6 Global Key Players of Therapeutic Proteins and Oral Vaccines, Product and Application
3.7 Global Key Players of Therapeutic Proteins and Oral Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Proteins and Oral Vaccines Breakdown Data by Type
4.1 Global Therapeutic Proteins and Oral Vaccines Historic Market Size by Type (2020-2025)
4.2 Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Type (2026-2031)
5 Therapeutic Proteins and Oral Vaccines Breakdown Data by Application
5.1 Global Therapeutic Proteins and Oral Vaccines Historic Market Size by Application (2020-2025)
5.2 Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Therapeutic Proteins and Oral Vaccines Market Size (2020-2031)
6.2 North America Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025)
6.4 North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Proteins and Oral Vaccines Market Size (2020-2031)
7.2 Europe Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025)
7.4 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size (2020-2031)
8.2 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025)
8.4 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Proteins and Oral Vaccines Market Size (2020-2031)
9.2 Latin America Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025)
9.4 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size (2020-2031)
10.2 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025)
10.4 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Therapeutic Proteins and Oral Vaccines Introduction
11.1.4 Abbott Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Therapeutic Proteins and Oral Vaccines Introduction
11.2.4 Amgen Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Therapeutic Proteins and Oral Vaccines Introduction
11.3.4 Biogen Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.3.5 Biogen Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Introduction
11.4.4 Eli Lilly and Company Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.4.5 Eli Lilly and Company Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Therapeutic Proteins and Oral Vaccines Introduction
11.5.4 Roche Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Details
11.6.2 Johnson and Johnson Business Overview
11.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Introduction
11.6.4 Johnson and Johnson Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.6.5 Johnson and Johnson Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Therapeutic Proteins and Oral Vaccines Introduction
11.7.4 Merck Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.7.5 Merck Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Details
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Introduction
11.8.4 Novo Nordisk Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.8.5 Novo Nordisk Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Introduction
11.9.4 Pfizer Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Introduction
11.10.4 Sanofi Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.10.5 Sanofi Recent Development
11.11 Serum Institute of India
11.11.1 Serum Institute of India Company Details
11.11.2 Serum Institute of India Business Overview
11.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Introduction
11.11.4 Serum Institute of India Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.11.5 Serum Institute of India Recent Development
11.12 Emergent Biosolutions
11.12.1 Emergent Biosolutions Company Details
11.12.2 Emergent Biosolutions Business Overview
11.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Introduction
11.12.4 Emergent Biosolutions Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.12.5 Emergent Biosolutions Recent Development
11.13 TransAlgae
11.13.1 TransAlgae Company Details
11.13.2 TransAlgae Business Overview
11.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Introduction
11.13.4 TransAlgae Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.13.5 TransAlgae Recent Development
11.14 MigVax
11.14.1 MigVax Company Details
11.14.2 MigVax Business Overview
11.14.3 MigVax Therapeutic Proteins and Oral Vaccines Introduction
11.14.4 MigVax Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.14.5 MigVax Recent Development
11.15 Lumen Bioscience
11.15.1 Lumen Bioscience Company Details
11.15.2 Lumen Bioscience Business Overview
11.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Introduction
11.15.4 Lumen Bioscience Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
11.15.5 Lumen Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott
Amgen Inc
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer Inc
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience
List of Tables
 Table 1. Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Therapeutic Proteins
 Table 3. Key Players of Oral Vaccines
 Table 4. Global Therapeutic Proteins and Oral Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Therapeutic Proteins and Oral Vaccines Market Share by Region (2020-2025)
 Table 8. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Therapeutic Proteins and Oral Vaccines Market Share by Region (2026-2031)
 Table 10. Therapeutic Proteins and Oral Vaccines Market Trends
 Table 11. Therapeutic Proteins and Oral Vaccines Market Drivers
 Table 12. Therapeutic Proteins and Oral Vaccines Market Challenges
 Table 13. Therapeutic Proteins and Oral Vaccines Market Restraints
 Table 14. Global Therapeutic Proteins and Oral Vaccines Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Therapeutic Proteins and Oral Vaccines Market Share by Players (2020-2025)
 Table 16. Global Top Therapeutic Proteins and Oral Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Proteins and Oral Vaccines as of 2024)
 Table 17. Ranking of Global Top Therapeutic Proteins and Oral Vaccines Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Therapeutic Proteins and Oral Vaccines Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Therapeutic Proteins and Oral Vaccines, Headquarters and Area Served
 Table 20. Global Key Players of Therapeutic Proteins and Oral Vaccines, Product and Application
 Table 21. Global Key Players of Therapeutic Proteins and Oral Vaccines, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Therapeutic Proteins and Oral Vaccines Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type (2020-2025)
 Table 25. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type (2026-2031)
 Table 27. Global Therapeutic Proteins and Oral Vaccines Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Application (2020-2025)
 Table 29. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Application (2026-2031)
 Table 31. North America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Company Details
 Table 47. Abbott Business Overview
 Table 48. Abbott Therapeutic Proteins and Oral Vaccines Product
 Table 49. Abbott Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 50. Abbott Recent Development
 Table 51. Amgen Company Details
 Table 52. Amgen Business Overview
 Table 53. Amgen Therapeutic Proteins and Oral Vaccines Product
 Table 54. Amgen Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 55. Amgen Recent Development
 Table 56. Biogen Company Details
 Table 57. Biogen Business Overview
 Table 58. Biogen Therapeutic Proteins and Oral Vaccines Product
 Table 59. Biogen Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 60. Biogen Recent Development
 Table 61. Eli Lilly and Company Company Details
 Table 62. Eli Lilly and Company Business Overview
 Table 63. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product
 Table 64. Eli Lilly and Company Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 65. Eli Lilly and Company Recent Development
 Table 66. Roche Company Details
 Table 67. Roche Business Overview
 Table 68. Roche Therapeutic Proteins and Oral Vaccines Product
 Table 69. Roche Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 70. Roche Recent Development
 Table 71. Johnson and Johnson Company Details
 Table 72. Johnson and Johnson Business Overview
 Table 73. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product
 Table 74. Johnson and Johnson Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 75. Johnson and Johnson Recent Development
 Table 76. Merck Company Details
 Table 77. Merck Business Overview
 Table 78. Merck Therapeutic Proteins and Oral Vaccines Product
 Table 79. Merck Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 80. Merck Recent Development
 Table 81. Novo Nordisk Company Details
 Table 82. Novo Nordisk Business Overview
 Table 83. Novo Nordisk Therapeutic Proteins and Oral Vaccines Product
 Table 84. Novo Nordisk Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 85. Novo Nordisk Recent Development
 Table 86. Pfizer Company Details
 Table 87. Pfizer Business Overview
 Table 88. Pfizer Therapeutic Proteins and Oral Vaccines Product
 Table 89. Pfizer Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 90. Pfizer Recent Development
 Table 91. Sanofi Company Details
 Table 92. Sanofi Business Overview
 Table 93. Sanofi Therapeutic Proteins and Oral Vaccines Product
 Table 94. Sanofi Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 95. Sanofi Recent Development
 Table 96. Serum Institute of India Company Details
 Table 97. Serum Institute of India Business Overview
 Table 98. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product
 Table 99. Serum Institute of India Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 100. Serum Institute of India Recent Development
 Table 101. Emergent Biosolutions Company Details
 Table 102. Emergent Biosolutions Business Overview
 Table 103. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product
 Table 104. Emergent Biosolutions Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 105. Emergent Biosolutions Recent Development
 Table 106. TransAlgae Company Details
 Table 107. TransAlgae Business Overview
 Table 108. TransAlgae Therapeutic Proteins and Oral Vaccines Product
 Table 109. TransAlgae Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 110. TransAlgae Recent Development
 Table 111. MigVax Company Details
 Table 112. MigVax Business Overview
 Table 113. MigVax Therapeutic Proteins and Oral Vaccines Product
 Table 114. MigVax Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 115. MigVax Recent Development
 Table 116. Lumen Bioscience Company Details
 Table 117. Lumen Bioscience Business Overview
 Table 118. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product
 Table 119. Lumen Bioscience Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025) & (US$ Million)
 Table 120. Lumen Bioscience Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Therapeutic Proteins and Oral Vaccines Picture
 Figure 2. Global Therapeutic Proteins and Oral Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Therapeutic Proteins and Oral Vaccines Market Share by Type: 2024 VS 2031
 Figure 4. Therapeutic Proteins Features
 Figure 5. Oral Vaccines Features
 Figure 6. Global Therapeutic Proteins and Oral Vaccines Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Therapeutic Proteins and Oral Vaccines Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Pharmacies Case Studies
 Figure 9. Retail Pharmacies Case Studies
 Figure 10. Online Pharmacies Case Studies
 Figure 11. Therapeutic Proteins and Oral Vaccines Report Years Considered
 Figure 12. Global Therapeutic Proteins and Oral Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Therapeutic Proteins and Oral Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Therapeutic Proteins and Oral Vaccines Market Share by Region: 2024 VS 2031
 Figure 15. Global Therapeutic Proteins and Oral Vaccines Market Share by Players in 2024
 Figure 16. Global Top Therapeutic Proteins and Oral Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Proteins and Oral Vaccines as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Therapeutic Proteins and Oral Vaccines Revenue in 2024
 Figure 18. North America Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Therapeutic Proteins and Oral Vaccines Market Share by Country (2020-2031)
 Figure 20. United States Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Therapeutic Proteins and Oral Vaccines Market Share by Country (2020-2031)
 Figure 24. Germany Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Share by Region (2020-2031)
 Figure 32. China Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Therapeutic Proteins and Oral Vaccines Market Share by Country (2020-2031)
 Figure 40. Mexico Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Share by Country (2020-2031)
 Figure 44. Turkey Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Abbott Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 48. Amgen Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 49. Biogen Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 50. Eli Lilly and Company Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 51. Roche Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 52. Johnson and Johnson Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 53. Merck Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 54. Novo Nordisk Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 55. Pfizer Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 56. Sanofi Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 57. Serum Institute of India Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 58. Emergent Biosolutions Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 59. TransAlgae Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 60. MigVax Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 61. Lumen Bioscience Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Vaccine for Human Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Vaccine Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Vaccines Administered Orally Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Oral Vaccine Market Research Report 2024
Orally Administered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Administered Orally Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Delivery Vaccines Market Research Report 2025
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Oral Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Vaccines Solutions for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Proteins and Peptides Market Research Report 2025
Global Plasma Protein Therapeutics Market Research Report 2025
Global Oral Vaccine Adjuvants Market Research Report 2025
Global Human Vaccination Market Research Report 2025
Global Recombinant Therapeutic Protein Market Research Report 2025
Oral Live Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions